Stay updated on Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.2 to v3.8.0 while the study page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T16:45:45.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH website updates and a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T20:21:42.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T20:25:00.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T20:39:23.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The 403 error page and related boilerplate HTML have been removed, and the Home navigation reference appears to be deleted, indicating the study details page is now accessible instead of the error screen.
    Difference
    0.5%
    Check dated 2026-09-26T20:34:11.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, replacing the previous study record content with a minimal error screen. The additions show a 403 header and basic navigation, while the lengthy study-related content is removed, reflecting an access-restricted state.
    Difference
    20%
    Check dated 2026-09-19T20:52:22.000Z thumbnail image

Stay in the know with updates to Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab for Liver Cancer Clinical Trial page.